An Open-Label, Expanded Access Protocol of LAM-002A in C9ORF72-Associated Frontotemporal Dementia (FTD)
NCT05483322
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Frontotemporal Dementia
Interventions
DRUG:
LAM-002A
Sponsor
OrphAI Therapeutics